Infectious disease test kit

immunityIgGphosphate

The SARS-CoV-2 IgG ELISA kit is an in vitro diagnostic test for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum. The kit is intended for use as an aid in identifying individuals with an adaptive immune response to SARS- CoV-2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. The SARS-CoV-2 IgG ELISA KIT should not be used to diagnose acute SARS‑CoV‑2 infection. Results are for the detection of IgG SARS-CoV-2 antibodies. IgG antibodies to SARS-CoV-2 are generally detectable in the blood several days after initial infection, although the duration of time antibodies are present post-infection is not well characterized. Individuals may have a detectable virus present for several weeks following seroconversion. The sensitivity of SARSARS-CoV-2 IgG ELISA early after infection is unknown. Negative results do not preclude acute SARS-CoV-2 infection. If the acute infection is suspected, direct testing for SARS-CoV-2 is necessary. False positive results for SARS-CoV-2 IgG ELISA may occur due to cross-reactivity from pre-existing antibodies or other possible causes. Kit content SARS-CoV-2 Antigen Coated Microtiter Plate: 1×96 well Strip holder in a resealable foil pouch, containing 96 polystyrene microtiter wells coated with SARS-CoV-2 antigen in each well. Sample dilution Buffer (DIL): 2×15,5 mL Sample Dilution Buffer will be used for the dilution of test samples and controls. Phosphate buffer pH 7.40, NaCl, KCl, Proclin 300, Interference masking agent.